Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

PURPOSE: Iodine-131—metaiodobenzylguanidine ((131)I-MIBG) provides targeted radiotherapy with more than 30% response rate in refractory neuroblastoma, but activity infused is limited by radiation safety and hematologic toxicity. The goal was to determine the maximum-tolerated dose of (131)I-MIBG in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Matthay, Katherine K., Quach, Alekist, Huberty, John, Franc, Benjamin L., Hawkins, Randall A., Jackson, Hollie, Groshen, Susan, Shusterman, Suzanne, Yanik, Gregory, Veatch, Janet, Brophy, Patricia, Villablanca, Judith G., Maris, John M.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2009
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738616/
https://ncbi.nlm.nih.gov/pubmed/19171714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.7628
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items